US Stock MarketDetailed Quotes

Allogene Therapeutics (ALLO)

Watchlist

2.370
+0.200+9.22%

Close Apr 16 16:00 ET

2.400
+0.030+1.26%

Pre 07:20 ET

785.13MMarket Cap-2.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Allogene Therapeutics (ALLO) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

-76.84%22K

-26.67%22K

Operating revenue

--0

-76.84%22K

--0

-26.67%22K

Cost of revenue

Gross profit

Operating expense

-19.64%206.93M

-29.90%42.4M

-26.45%44.9M

-18.07%54.44M

-6.24%65.19M

-18.15%257.5M

-15.85%60.49M

-3.13%61.05M

-17.53%66.44M

-29.86%69.53M

Selling and administrative expenses

-12.92%56.78M

-11.25%13.77M

-15.89%13.74M

-11.23%14.28M

-13.18%14.99M

-9.02%65.21M

-9.90%15.52M

-4.15%16.33M

-13.16%16.09M

-8.56%17.27M

-General and administrative expense

-12.92%56.78M

-11.25%13.77M

-15.89%13.74M

-11.23%14.28M

-13.18%14.99M

-9.02%65.21M

-9.90%15.52M

-4.15%16.33M

-13.16%16.09M

-8.56%17.27M

Research and development costs

-21.92%150.15M

-36.33%28.63M

-30.30%31.16M

-20.25%40.16M

-3.94%50.2M

-20.84%192.3M

-17.73%44.97M

-2.75%44.71M

-18.83%50.36M

-34.87%52.26M

Operating profit

19.63%-206.93M

29.90%-42.4M

26.45%-44.9M

18.07%-54.44M

6.21%-65.19M

18.13%-257.48M

15.83%-60.49M

3.10%-61.05M

17.50%-66.44M

29.86%-69.5M

Net non-operating interest income expense

-8.80%18.21M

13.61%3.35M

-45.77%3.58M

18.66%5.92M

-1.23%5.37M

9.09%19.97M

-52.98%2.95M

6.45%6.61M

32.03%4.99M

163.87%5.43M

Non-operating interest income

-4.29%19.29M

20.91%3.66M

-41.45%3.93M

24.04%6.19M

1.53%5.52M

10.08%20.15M

-51.68%3.03M

8.06%6.71M

32.03%4.99M

163.87%5.43M

Non-operating interest expense

493.92%1.08M

286.42%313K

244.00%344K

--268K

--150K

--181K

--81K

--100K

--0

Other net income (expense)

88.96%-2.17M

112.65%247K

99.32%-81K

50.55%-2.43M

109.90%92K

36.82%-19.64M

90.33%-1.95M

-115.65%-11.85M

-98.54%-4.9M

68.35%-929K

Special income (charges)

84.84%-2.38M

--0

52.25%-2.38M

----

-18.66%-15.72M

--0

---10.73M

---4.99M

----

-Less:Impairment of capital assets

-84.84%2.38M

--0

-52.25%2.38M

----

18.66%15.72M

--0

--10.73M

--4.99M

----

Other non- operating income (expenses)

105.48%215K

112.65%247K

92.79%-81K

-150.59%-43K

109.90%92K

78.02%-3.92M

71.85%-1.95M

79.55%-1.12M

103.44%85K

68.35%-929K

Income before tax

25.77%-190.89M

34.77%-38.81M

37.55%-41.4M

23.23%-50.94M

8.10%-59.73M

21.43%-257.15M

30.64%-59.5M

-6.43%-66.29M

16.25%-66.36M

34.98%-65M

Income tax

443K

Net income

25.90%-190.89M

35.25%-38.81M

37.55%-41.4M

23.23%-50.94M

8.10%-59.73M

21.29%-257.59M

30.12%-59.94M

-6.43%-66.29M

16.25%-66.36M

34.98%-65M

Net income continuous Operations

25.90%-190.89M

35.25%-38.81M

37.55%-41.4M

23.23%-50.94M

8.10%-59.73M

21.29%-257.59M

30.12%-59.94M

-6.43%-66.29M

16.25%-66.36M

34.98%-65M

Minority interest income

Net income attributable to the parent company

25.90%-190.89M

35.25%-38.81M

37.55%-41.4M

23.23%-50.94M

8.10%-59.73M

21.29%-257.59M

30.12%-59.94M

-6.43%-66.29M

16.25%-66.36M

34.98%-65M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

25.90%-190.89M

35.25%-38.81M

37.55%-41.4M

23.23%-50.94M

8.10%-59.73M

21.29%-257.59M

30.12%-59.94M

-6.43%-66.29M

16.25%-66.36M

34.98%-65M

Basic earnings per share

34.09%-0.87

39.29%-0.17

40.63%-0.19

34.29%-0.23

26.32%-0.28

36.84%-1.32

45.10%-0.28

13.51%-0.32

35.19%-0.35

44.93%-0.38

Diluted earnings per share

34.09%-0.87

39.29%-0.17

40.63%-0.19

34.29%-0.23

26.32%-0.28

36.84%-1.32

45.10%-0.28

13.51%-0.32

35.19%-0.35

44.93%-0.38

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	0	0	0	0	0	-76.84%22K	0	0	0	-26.67%22K
Operating revenue	--0	--0	--0	--0	--0	-76.84%22K	--0	--0	--0	-26.67%22K
Cost of revenue
Gross profit
Operating expense	-19.64%206.93M	-29.90%42.4M	-26.45%44.9M	-18.07%54.44M	-6.24%65.19M	-18.15%257.5M	-15.85%60.49M	-3.13%61.05M	-17.53%66.44M	-29.86%69.53M
Selling and administrative expenses	-12.92%56.78M	-11.25%13.77M	-15.89%13.74M	-11.23%14.28M	-13.18%14.99M	-9.02%65.21M	-9.90%15.52M	-4.15%16.33M	-13.16%16.09M	-8.56%17.27M
-General and administrative expense	-12.92%56.78M	-11.25%13.77M	-15.89%13.74M	-11.23%14.28M	-13.18%14.99M	-9.02%65.21M	-9.90%15.52M	-4.15%16.33M	-13.16%16.09M	-8.56%17.27M
Research and development costs	-21.92%150.15M	-36.33%28.63M	-30.30%31.16M	-20.25%40.16M	-3.94%50.2M	-20.84%192.3M	-17.73%44.97M	-2.75%44.71M	-18.83%50.36M	-34.87%52.26M
Operating profit	19.63%-206.93M	29.90%-42.4M	26.45%-44.9M	18.07%-54.44M	6.21%-65.19M	18.13%-257.48M	15.83%-60.49M	3.10%-61.05M	17.50%-66.44M	29.86%-69.5M
Net non-operating interest income expense	-8.80%18.21M	13.61%3.35M	-45.77%3.58M	18.66%5.92M	-1.23%5.37M	9.09%19.97M	-52.98%2.95M	6.45%6.61M	32.03%4.99M	163.87%5.43M
Non-operating interest income	-4.29%19.29M	20.91%3.66M	-41.45%3.93M	24.04%6.19M	1.53%5.52M	10.08%20.15M	-51.68%3.03M	8.06%6.71M	32.03%4.99M	163.87%5.43M
Non-operating interest expense	493.92%1.08M	286.42%313K	244.00%344K	--268K	--150K	--181K	--81K	--100K	--0	--0
Other net income (expense)	88.96%-2.17M	112.65%247K	99.32%-81K	50.55%-2.43M	109.90%92K	36.82%-19.64M	90.33%-1.95M	-115.65%-11.85M	-98.54%-4.9M	68.35%-929K
Special income (charges)	84.84%-2.38M	--0	--0	52.25%-2.38M	----	-18.66%-15.72M	--0	---10.73M	---4.99M	----
-Less:Impairment of capital assets	-84.84%2.38M	--0	--0	-52.25%2.38M	----	18.66%15.72M	--0	--10.73M	--4.99M	----
Other non- operating income (expenses)	105.48%215K	112.65%247K	92.79%-81K	-150.59%-43K	109.90%92K	78.02%-3.92M	71.85%-1.95M	79.55%-1.12M	103.44%85K	68.35%-929K
Income before tax	25.77%-190.89M	34.77%-38.81M	37.55%-41.4M	23.23%-50.94M	8.10%-59.73M	21.43%-257.15M	30.64%-59.5M	-6.43%-66.29M	16.25%-66.36M	34.98%-65M
Income tax	0					443K
Net income	25.90%-190.89M	35.25%-38.81M	37.55%-41.4M	23.23%-50.94M	8.10%-59.73M	21.29%-257.59M	30.12%-59.94M	-6.43%-66.29M	16.25%-66.36M	34.98%-65M
Net income continuous Operations	25.90%-190.89M	35.25%-38.81M	37.55%-41.4M	23.23%-50.94M	8.10%-59.73M	21.29%-257.59M	30.12%-59.94M	-6.43%-66.29M	16.25%-66.36M	34.98%-65M
Minority interest income
Net income attributable to the parent company	25.90%-190.89M	35.25%-38.81M	37.55%-41.4M	23.23%-50.94M	8.10%-59.73M	21.29%-257.59M	30.12%-59.94M	-6.43%-66.29M	16.25%-66.36M	34.98%-65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	25.90%-190.89M	35.25%-38.81M	37.55%-41.4M	23.23%-50.94M	8.10%-59.73M	21.29%-257.59M	30.12%-59.94M	-6.43%-66.29M	16.25%-66.36M	34.98%-65M
Basic earnings per share	34.09%-0.87	39.29%-0.17	40.63%-0.19	34.29%-0.23	26.32%-0.28	36.84%-1.32	45.10%-0.28	13.51%-0.32	35.19%-0.35	44.93%-0.38
Diluted earnings per share	34.09%-0.87	39.29%-0.17	40.63%-0.19	34.29%-0.23	26.32%-0.28	36.84%-1.32	45.10%-0.28	13.51%-0.32	35.19%-0.35	44.93%-0.38
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm